These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 18497564)

  • 1. Involvement of c-jun in human liposarcoma growth: supporting data from clinical immunohistochemistry and DNAzyme efficacy.
    Dass CR; Galloway SJ; Clark JC; Khachigian LM; Choong PF
    Cancer Biol Ther; 2008 Aug; 7(8):1297-301. PubMed ID: 18497564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Jun Is critical for the progression of osteosarcoma: proof in an orthotopic spontaneously metastasizing model.
    Dass CR; Khachigian LM; Choong PF
    Mol Cancer Res; 2008 Aug; 6(8):1289-92. PubMed ID: 18708361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of c-jun results in apoptosis-mediated anti-osteosarcoma activity in an orthotopic model.
    Dass CR; Friedhuber AM; Khachigian LM; Dunstan DE; Choong PF
    Cancer Biol Ther; 2008 Jul; 7(7):1033-6. PubMed ID: 18414033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Players in human liposarcoma: JUN joins the cast.
    Cobaleda C; Jimenez R; Sanchez-Garcia I
    Cancer Biol Ther; 2008 Aug; 7(8):1302-4. PubMed ID: 18708756
    [No Abstract]   [Full Text] [Related]  

  • 5. c-Jun knockdown sensitizes osteosarcoma to doxorubicin.
    Dass CR; Khachigian LM; Choong PF
    Mol Cancer Ther; 2008 Jul; 7(7):1909-12. PubMed ID: 18645001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Jun amplification and overexpression are oncogenic in liposarcoma but not always sufficient to inhibit the adipocytic differentiation programme.
    Snyder EL; Sandstrom DJ; Law K; Fiore C; Sicinska E; Brito J; Bailey D; Fletcher JA; Loda M; Rodig SJ; Dal Cin P; Fletcher CD
    J Pathol; 2009 Jul; 218(3):292-300. PubMed ID: 19449367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of deoxyribozymes targeting c-Jun on solid tumor growth and angiogenesis in rodents.
    Zhang G; Dass CR; Sumithran E; Di Girolamo N; Sun LQ; Khachigian LM
    J Natl Cancer Inst; 2004 May; 96(9):683-96. PubMed ID: 15126605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNAzyme targeting c-jun suppresses skin cancer growth.
    Cai H; Santiago FS; Prado-Lourenco L; Wang B; Patrikakis M; Davenport MP; Maghzal GJ; Stocker R; Parish CR; Chong BH; Lieschke GJ; Wong TW; Chesterman CN; Francis DJ; Moloney FJ; Barnetson RS; Halliday GM; Khachigian LM
    Sci Transl Med; 2012 Jun; 4(139):139ra82. PubMed ID: 22723462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanism and therapeutic implications of selinexor (KPT-330) in liposarcoma.
    Garg M; Kanojia D; Mayakonda A; Said JW; Doan NB; Chien W; Ganesan TS; Chuang LS; Venkatachalam N; Baloglu E; Shacham S; Kauffman M; Koeffler HP
    Oncotarget; 2017 Jan; 8(5):7521-7532. PubMed ID: 27893412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of Fas/FasL-mediated apoptosis by luteolin through enhancement of histone H3 acetylation and c-Jun activation in HL-60 leukemia cells.
    Wang SW; Chen YR; Chow JM; Chien MH; Yang SF; Wen YC; Lee WJ; Tseng TH
    Mol Carcinog; 2018 Jul; 57(7):866-877. PubMed ID: 29566277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical roles for JNK, c-Jun, and Fas/FasL-Signaling in vitamin E analog-induced apoptosis in human prostate cancer cells.
    Jia L; Yu W; Wang P; Li J; Sanders BG; Kline K
    Prostate; 2008 Mar; 68(4):427-41. PubMed ID: 18196534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dz13, a DNAzyme targeting c-jun, induces off-target cytotoxicity in endothelial cells with features of nonapoptotic programmed cell death.
    Gozar MM; Goodchild A; Passioura T; King A; Lai A; Witherington C; Rivory L
    Oligonucleotides; 2008 Sep; 18(3):257-68. PubMed ID: 18699742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma protective antitumor immunity activated by catalytic DNA.
    Cai H; Cho EA; Li Y; Sockler J; Parish CR; Chong BH; Edwards J; Dodds TJ; Ferguson PM; Wilmott JS; Scolyer RA; Halliday GM; Khachigian LM
    Oncogene; 2018 Sep; 37(37):5115-5126. PubMed ID: 29844573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JUN oncogene amplification and overexpression block adipocytic differentiation in highly aggressive sarcomas.
    Mariani O; Brennetot C; Coindre JM; Gruel N; Ganem C; Delattre O; Stern MH; Aurias A
    Cancer Cell; 2007 Apr; 11(4):361-74. PubMed ID: 17418412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dz13: c-Jun downregulation and tumour cell death.
    Elahy M; Dass CR
    Chem Biol Drug Des; 2011 Dec; 78(6):909-12. PubMed ID: 21722318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dz13, a c-jun DNAzyme, is a potent inducer of caspase-2 activation.
    Dass CR; Galloway SJ; Choong PF
    Oligonucleotides; 2010 Jun; 20(3):137-46. PubMed ID: 20180631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting the mTOR pathway synergistically enhances cytotoxicity in ovarian cancer cells induced by etoposide through upregulation of c-Jun.
    Itamochi H; Oishi T; Shimada M; Sato S; Uegaki K; Naniwa J; Sato S; Nonaka M; Terakawa N; Kigawa J; Harada T
    Clin Cancer Res; 2011 Jul; 17(14):4742-50. PubMed ID: 21610153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronan-CD44 interaction promotes HPV 16 E6 oncogene-mediated oropharyngeal cell carcinoma survival and chemoresistance.
    Bourguignon LYW; Earle C; Shiina M
    Matrix Biol; 2019 May; 78-79():180-200. PubMed ID: 30077625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR200c attenuates P-gp-mediated MDR and metastasis by targeting JNK2/c-Jun signaling pathway in colorectal cancer.
    Sui H; Cai GX; Pan SF; Deng WL; Wang YW; Chen ZS; Cai SJ; Zhu HR; Li Q
    Mol Cancer Ther; 2014 Dec; 13(12):3137-51. PubMed ID: 25205654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperation between STAT3 and c-jun suppresses Fas transcription.
    Ivanov VN; Bhoumik A; Krasilnikov M; Raz R; Owen-Schaub LB; Levy D; Horvath CM; Ronai Z
    Mol Cell; 2001 Mar; 7(3):517-28. PubMed ID: 11463377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.